Papers/PMID:32295807
Dietary Manganese, Plasma Markers of Inflammation, and the Development of Type 2 Diabetes in Postmenopausal Women: Findings From the Women's Health Initiative.
Diabetes care2020The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
Mn(2+) — decreases type 2 diabetes incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Compared with the lowest quintile of energy-adjusted dietary manganese, WHI-OS participants in the highest quintile had a 30% lower risk of type 2 diabetes (hazard ratio [HR] 0.70 [95% CI 0.65, 0.76]).”
Quoted verbatim from Dietary Manganese, Plasma Markers of Inflammation, and the Development of Type 2 Diabetes in Postmenopausal Women: Findings From the Women's Health Initiative.. - Study
- cohort
- Dose
- highest versus lowest quintile of energy-adjusted dietary manganese intake
- Population
- Postmenopausal women without a history of diabetes in the Women's Health Initiative Observational Study; highest versus lowest quintile of energy-adjusted dietary manganese intake
Effect 0.7 hazard ratio, 95% CI 0.65 to 0.76
Dietary Manganese, Plasma Markers of Inflammation, and the Development of Type 2 Diabetes in Postmenopausal Women: Findings From the Women's Health Initiative.2020PMID:32295807Permalink